Table 1 Experimental and predicted steady-state concentrations
From: Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue
Predicted value mean±s.d. | Measured value | Cancer type and References | |
---|---|---|---|
VEGF (pmol/l)a | 178±8 | 8–389 | Multiple, compiled in ref. 22 |
TSP1 | |||
Total (pmol) | 61±4 | 52–64b | Breast34 Hepatocellular carcinoma35 |
Unbound (pmol/l)a | 185±5 | c | |
Cleaved (nmol/l)a | 2.2±0.06 | c | |
MMP3 | |||
Total (pmol) | 162±0.02 | 160b | Oral squamous cell carcinoma33 |
Unbound (nmol/l)a | 9.0±5×10−3 | c | |
MMP9 | |||
Total (pmol) | 161±0.1 | 160b | Oral squamous cell carcinoma33 |
Active (% of total) | 3%±8×10−4% | 8% | Oral squamous cell carcinoma33 |
Active (pmol/l)a | 295±7 | c |